We are live on ! Find out more
EAM

Erste Asset Management Portfolio holdings

AUM $12.9B
1-Year Est. Return 52.69%
This Fund
S&P 500
This Quarter Est. Return
+6.55%
1 Year Est. Return
+52.69%
3 Year Est. Return
+142.55%
5 Year Est. Return
+182.36%
10 Year Est. Return
AUM
$8.35B
AUM Growth
+$800M
Cap. Flow
+$504M
Cap. Flow %
6.04%
Top 10 Hldgs %
25.64%
Holding
584
New
37
Increased
219
Reduced
115
Closed
35

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$65.1M
2
NFLX icon
Netflix
NFLX
+$60.3M
3
UNH icon
UnitedHealth
UNH
+$26.9M
4
RSP icon
Invesco S&P 500 Equal Weight ETF
RSP
+$26.5M
5
MSFT icon
Microsoft
MSFT
+$22.4M

Top Sells

Rank Stock Value
1
GWW icon
W.W. Grainger
GWW
+$52.8M
2
CDNS icon
Cadence Design Systems
CDNS
+$16.1M
3
NOVA
Sunnova Energy
NOVA
+$13.8M
4
NKE icon
Nike
NKE
+$13M
5
TEAM icon
Atlassian
TEAM
+$11.2M

Sector Composition

Rank Sector Weight
1 Technology 35.05%
2 Healthcare 16.36%
3 Financials 12.4%
4 Consumer Discretionary 9%
5 Communication Services 8.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KMI icon
351
Kinder Morgan
KMI
$69.3B
$1.45M 0.02%
66,500
+4,500
+7% +$94.8K
IDXX icon
352
Idexx Laboratories
IDXX
$46.1B
$1.43M 0.02%
2,790
STLD icon
353
Steel Dynamics
STLD
$38.1B
$1.42M 0.02%
11,295
-35,575
-76% -$4.32M
NU icon
354
Nu Holdings
NU
$69.9B
$1.39M 0.02%
100,000
DCBO
355
Docebo
DCBO
$523M
$1.35M 0.02%
30,400
TRGP icon
356
Targa Resources
TRGP
$55.8B
$1.34M 0.02%
9,100
-300
-3% -$42.2K
EXC icon
357
Exelon
EXC
$47.1B
$1.33M 0.02%
+32,761
New +$1.23M
AKRO
358
DELISTED
Akero Therapeutics
AKRO
$1.33M 0.02%
47,000
CCI icon
359
Crown Castle
CCI
$32.3B
$1.32M 0.02%
11,300
KYMR icon
360
Kymera Therapeutics
KYMR
$8.68B
$1.31M 0.02%
27,000
EW icon
361
Edwards Lifesciences
EW
$51.3B
$1.3M 0.02%
19,494
-145,848
-88% -$10.6M
WY icon
362
Weyerhaeuser
WY
$18.6B
$1.28M 0.02%
38,000
GLPI icon
363
Gaming and Leisure Properties
GLPI
$12.7B
$1.27M 0.02%
25,100
WPC icon
364
W.P. Carey
WPC
$16.4B
$1.27M 0.02%
20,200
FOLD
365
DELISTED
Amicus Therapeutics
FOLD
$1.25M 0.02%
116,850
ENTA icon
366
Enanta Pharmaceuticals
ENTA
$384M
$1.24M 0.01%
120,000
APLS
367
DELISTED
Apellis Pharmaceuticals
APLS
$1.24M 0.01%
42,000
TRP icon
368
TC Energy
TRP
$66.5B
$1.22M 0.01%
+26,000
New +$1.13M
HLNE icon
369
Hamilton Lane
HLNE
$5.56B
$1.21M 0.01%
7,198
-354
-5% -$51.2K
RVMD icon
370
Revolution Medicines
RVMD
$41.9B
$1.21M 0.01%
27,400
BDX icon
371
Becton Dickinson
BDX
$47B
$1.21M 0.01%
4,998
+446
+10% +$105K
CTRE icon
372
CareTrust REIT
CTRE
$9.65B
$1.21M 0.01%
39,200
+4,100
+12% +$116K
JD icon
373
JD.com
JD
$43.9B
$1.2M 0.01%
30,000
KROS icon
374
Keros Therapeutics
KROS
$198M
$1.17M 0.01%
20,700
NUVL
375
DELISTED
Nuvalent
NUVL
$1.14M 0.01%
11,500

Similar funds

Erste Asset Management's Q3 2024 Portfolio in Review

As of Q3 2024, Erste Asset Management held 584 positions worth $8.35B, up 11% from $7.55B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Erste Asset Management deployed $504M of net new capital in Q3 2024, opening 37 new positions and adding to 219 existing holdings. Its largest new stake was Cheniere Energy: 93,123 shares worth $16.8M.

By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 36% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was W.W. Grainger, an estimated $52.8M trimmed.

  • Erste Asset Management's largest Q3 2024 buy was Cheniere Energy: 93,123 shares worth $16.8M.
  • Erste Asset Management added most to NVIDIA in Q3 2024, an estimated $65.1M increase.
  • Erste Asset Management's biggest Q3 2024 reduction was W.W. Grainger, cutting an estimated $52.8M.
  • Erste Asset Management fully exited Pinterest in Q3 2024, selling an estimated $9.18M.
  • Erste Asset Management's ten largest holdings make up 26% of its $8.35B portfolio in Q3 2024.
  • Erste Asset Management opened 37 new positions and closed 35 in Q3 2024.
  • Erste Asset Management's portfolio value rose 11% quarter-over-quarter to $8.35B.

Based on Erste Asset Management's 13F filing for Q3 2024, filed 14 Nov 2024.